Global Organ Preservation Solutions Market Is Anticipated To Witness Growth Due To Growing Organ Transplantation Procedures And Rising Incidences Of Chronic Kidney Diseases

 

Organ Preservation Solutions Market 

Overview:

Organ preservation solutions are the basic substances that support organ storage, including impermeants, colloids, buffers, antioxidants, and nutrient precursors. These OPS are formulated to prevent ischemia-reperfusion injury (IRI) and maintain physiological organ function in the hypothermic environment of cold storage. Antioxidants, free radical scavengers and xanthine oxidase inhibitors have been widely used in the development of OPS to reduce ischemic/hypoxic injury. Common preservation solutions contain allopurinol and reduced glutathione, which are xanthine oxidase and free-radical scavengers. Inhibitors of nitric oxide synthase (NO) have also been developed and used as additives in preservation solutions. Amino acids have also been included in preservation solutions to provide cellular energy or act as metabolic substrates. Amino acids have shown to be quite effective in reducing IRI, and can be used as a replacement for glucose or sodium.

Market Dynamics:

 

Growing product approvals is estimated to augment growth of the global organ preservation solutions market over the forecast period. For instance, the university spinoff OrganOx, declared that they have gained premarket clearance from the FDA for their metra system in January 2022. OrganOx metra is an organ preservation device created by researchers in Biomedical Engineering and Surgery. Moreover, lack of skilled professionals is anticipated to restrain growth of the global organ preservation solutions market over the forecast period.

 

Impact of COVID-19:

 

COVID-19 was declared as a public health emergency in 2020 by the World Health Organization. The pandemic had a significant impact on almost all industries. The pandemic also had a huge impact on the healthcare sector. People became more aware of their health and hygiene. However, COVID-19 had an adverse impact on patients as it caused long-term damage to their vital organs like heart, lungs, liver and kidneys. This increased the demand for transplantable organs. This increased demand had a positive impact on the growth of the global organ preservation solutions market.

 

Key Takeaways:

 

The global organ preservation solutions market is expected to witness high growth, exhibiting CAGR of 16.5 over the forecast period, due to growing expansion by key players. For instance, OrganoPlate Caco-2, an assay ready product line was launched MIMETAS in March 2020. This product was developed to make the Organ-on-a-Chip technology available for everyone.

North America is anticipated to witness significant growth in the global organ preservation solutions market over the forecast period, owing to growing investments in healthcare infrastructure and rising incidences of chronic diseases.

Major players operating in the global organ preservation solutions market are Bridge to Life Ltd., XVIVO Perfusion, CryoLife, Inc., TransMedics, and 21st Century Medicine.